Publications by authors named "Toshiya Inaba"

Background Recent genomic analyses of poor prognostic and relapsed leukemia have revealed the involvement of diverse gene mutations in treatment resistance. These gene mutations are classified into two groups: mutations involving resistance to specific agents such as the  fusion gene mutations (typically T315I mutation) in tyrosine kinase inhibitor (TKI) resistance and those involving the resistance to diverse therapeutic modalities such as the  gene mutations. In the latter type, although their associations with drug resistance have been clinically demonstrated, the direct association with resistance to each therapeutic modality remains to be fully elucidated.

View Article and Find Full Text PDF

In childhood acute lymphoblastic leukemia (ALL), TP53 gene mutation is associated with chemoresistance in a certain population of relapsed cases. To directly verify the association of TP53 gene mutation with chemoresistance of relapsed childhood ALL cases and improve their prognosis, the development of appropriate human leukemia models having TP53 mutation in the intrinsic gene is required. Here, we sought to introduce R248Q hotspot mutation into the intrinsic TP53 gene in an ALL cell line, 697, by applying a prime editing (PE) system, which is a versatile genome editing technology.

View Article and Find Full Text PDF
Article Synopsis
  • A significant percentage of patients with acute myeloid leukemia (AML) relapse after standard chemotherapy, highlighting the need for more effective treatments.
  • Researchers developed a new anticancer drug, (R)-WAC-224 (R-WAC), which targets topoisomerase II and has shown strong anti-leukemia effects in lab tests.
  • R-WAC demonstrated less toxicity compared to traditional drugs like doxorubicin and improved survival in animal models, especially when combined with cytarabine, suggesting it could be a valuable new option for AML therapy.
View Article and Find Full Text PDF
Article Synopsis
  • * Myeloma cells release specific microRNAs (miR-106a-5p and miR-146a-5p) via exosomes, which enhance the induction of suppressive immune cells called M-MDSCs from healthy blood cells.
  • * These microRNAs work alongside other factors like CCL5 and MIF to upregulate molecules that contribute to immune suppression, suggesting new therapeutic approaches to improve immunotherapy effectiveness in MM.
View Article and Find Full Text PDF

Changes in the transcriptional machinery cause aberrant self-renewal of non-stem hematopoietic progenitors. AF10 fusions, such as CALM-AF10, are generated via chromosomal translocations, causing malignant leukemia. In this study, we demonstrate that AF10 fusion proteins cause aberrant self-renewal via ENL, which binds to MOZ/MORF lysine acetyltransferases (KATs).

View Article and Find Full Text PDF
Article Synopsis
  • * DDX41 is an RNA helicase critical for RNA metabolism and ribosome biogenesis, impacting the processing of pre-ribosomal RNA.
  • * Research using ribosome profiling revealed that reducing DDX41 levels affects the translation of various transcripts, suggesting a feedback mechanism that regulates ribosome biogenesis based on DDX41 activity.
View Article and Find Full Text PDF
Article Synopsis
  • - The use of gene-editing technology has accelerated developmental engineering, allowing for faster gene targeting in mice (2-3 months) compared to traditional embryonic stem cell methods (nearly 2 years).
  • - Genome-editing simplifies the process by eliminating several complicated steps, making it a more efficient technique.
  • - The review focuses on gene targeting's benefits in hematology and discusses the authors' findings related to chromosome 7's long arm in myeloid malignancies, emphasizing the importance of mouse models for understanding human diseases.
View Article and Find Full Text PDF

Myeloid malignancies with DDX41 mutations are often associated with bone marrow failure and cytopenia before overt disease manifestation. However, the mechanisms underlying these specific conditions remain elusive. Here, we demonstrate that loss of DDX41 function impairs efficient RNA splicing, resulting in DNA replication stress with excess R-loop formation.

View Article and Find Full Text PDF
Article Synopsis
  • - KMT2A-rearranged infant acute lymphoblastic leukemia (ALL) is a challenging type of childhood leukemia, and researchers conducted extensive genetic studies on 84 infants with this condition to understand its complexity.
  • - The analysis revealed five distinct clusters of the disease, each characterized by different genetic factors and stages of blood cell development, which include various types of IRX and HOXA gene involvement.
  • - A key finding is that specific mutations in the RAS pathway can predict patient outcomes, with one subgroup showing a high mutation rate and severe prognosis, emphasizing the need for personalized treatment strategies based on genetic insights.
View Article and Find Full Text PDF
Article Synopsis
  • Detailed analysis shows that genetic rearrangements of chromosome 3 drive certain myeloid leukemias by increasing EVI1 transcription through enhancer changes.
  • A novel EVI1 RNA variant, created by mutations in the splicing factor SF3B1, contributes to acute myeloid leukemia transformation and is frequently found in these patients.
  • Mutant SF3B1 promotes abnormal EVI1 splicing, enhancing stem cell self-renewal and accelerating leukemia development in mouse models, highlighting a crucial link between splicing mutations and myeloid leukemia pathogenesis.
View Article and Find Full Text PDF
Article Synopsis
  • p53 is a crucial protein that helps cells respond to DNA damage from radiation through processes like cell cycle arrest and apoptosis.
  • Researchers at The University of Tokyo discovered a new compound called STK160830 that acts as a radioprotector, mitigating the side effects of radiation therapy.
  • The study found that derivatives of STK160830 can inhibit p53 expression, which helps protect leukemia cells (MOLT-4) from radiation-induced cell death.
View Article and Find Full Text PDF

Glucocorticoid (GC) is a key drug in the treatment of B-cell precursor acute lymphoblastic leukemia (BCP-ALL), and the initial GC response is an important prognostic factor. GC receptors play an essential role in GC sensitivity, and somatic mutations of the GC receptor gene, NR3C1, are reportedly identified in some BCP-ALL cases, particularly at relapse. Moreover, associations of somatic mutations of the CREB-binding protein (CREBBP) and Wolf-Hirschhorn syndrome candidate 1 (WHSC1) genes with the GC-resistance of ALL have been suggested.

View Article and Find Full Text PDF
Article Synopsis
  • RNA synthesis inhibitors can help study whether biological processes need transcription or translation; however, verifying RNA dependence is tricky due to some inhibitors activating the p53 response.
  • The study identified STK160830, which exhibits anti-apoptotic effects in human T-cell leukemia and murine thymocytes, but shows little effect in p53-deficient cells, indicating its activity relies on the presence of p53.
  • STK160830 down-regulates various p53-related proteins and decreases mRNA levels similarly to another RNA synthesis inhibitor, actinomycin D, but it doesn't significantly increase p53 levels or cause the usual DNA damage response, making it a safer alternative for RNA synthesis inhibition.
View Article and Find Full Text PDF

Leukemic oncoproteins cause uncontrolled self-renewal of hematopoietic progenitors by aberrant gene activation, eventually causing leukemia. However, the molecular mechanism underlying aberrant gene activation remains elusive. Here, we showed that leukemic MLL fusion proteins associate with the HBO1 histone acetyltransferase (HAT) complex through their trithorax homology domain 2 (THD2) in various human cell lines.

View Article and Find Full Text PDF

HOXA9 is often highly expressed in leukemias. However, its precise roles in leukemogenesis remain elusive. Here, we show that HOXA9 maintains gene expression for multiple anti-apoptotic pathways to promote leukemogenesis.

View Article and Find Full Text PDF
Article Synopsis
  • - Revertant mosaicism is a natural process where spontaneous mutations correct genetic issues in patients with congenital disorders, potentially leading to positive effects, hence referred to as "natural gene therapy."
  • - Recent studies have shown that in patients with SAMD9/9L syndromes, this overcorrection can lead to serious conditions like myelodysplastic syndrome (MDS) and acute myelogenous leukemia (AML), specifically through changes involving chromosome 7.
  • - The review delves into the complex mechanisms connecting revertant mosaicism and cancer development, stressing the importance of myeloid tumor suppressors and the varying responses of mutated versus reverted cells to interferon.
View Article and Find Full Text PDF

Autosomal dominant sterile α motif domain containing 9 (Samd9) and Samd9L (Samd9/9L) syndromes are a large subgroup of currently established inherited bone marrow failure syndromes that includes myelodysplasia, infection, growth restriction, adrenal hypoplasia, genital phenotypes, and enteropathy (MIRAGE), ataxia pancytopenia, and familial monosomy 7 syndromes. Samd9/9L genes are located in tandem on chromosome 7 and have been known to be the genes responsible for myeloid malignancies associated with monosomy 7. Additionally, as IFN-inducible genes, Samd9/9L are crucial for protection against viruses.

View Article and Find Full Text PDF

Epigenetic regulation is essential for the maintenance of the hematopoietic system, and its deregulation is implicated in hematopoietic disorders. In this study, UTX, a demethylase for lysine 27 on histone H3 (H3K27) and a component of COMPASS-like and SWI/SNF complexes, played an essential role in the hematopoietic system by globally regulating aging-associated genes. Utx-deficient (UtxΔ/Δ) mice exhibited myeloid skewing with dysplasia, extramedullary hematopoiesis, impaired hematopoietic reconstituting ability, and increased susceptibility to leukemia, which are the hallmarks of hematopoietic aging.

View Article and Find Full Text PDF
Article Synopsis
  • Uncontrolled self-renewal of hematopoietic progenitors leads to leukemia, necessitating the continuous activation of specific genes that were active in the original cells.
  • The study reveals a transactivation system where the MLL protein recruits RNA polymerase II to activate transcription at CpG-rich promoters, with various transcriptional regulators playing key roles.
  • Leukemic fusion proteins, such as MOZ-TIF2 and MLL-AFX, disrupt normal gene regulation, but pharmacological inhibition of MLL or DOT1L can promote differentiation in affected cells, suggesting targeted therapies could be effective for different types of leukemia.
View Article and Find Full Text PDF

Exposure to high-doses of ionizing radiation has been reported to be associated with the risk of stroke. However, risks associated with lower dose exposures remain unclear, and there is little information available for the risk modification according to the dose-rate. There are few studies using animal models which might be able to provide complementary information on this association.

View Article and Find Full Text PDF
Article Synopsis
  • - Karyotype is a key factor in predicting outcomes in childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL), with asparaginase playing a crucial role in its chemotherapy by lowering serum asparagine levels, which BCP-ALL cells cannot produce effectively.
  • - The ASNS gene, important for asparagine production, is usually unmethylated in healthy cells but shows allele-specific methylation in BCP-ALL cells, indicating a potential epigenetic mechanism for its silencing.
  • - In studies of childhood BCP-ALL, increased methylation of the ASNS gene correlates with higher sensitivity to L-asparaginase treatment and is notably associated with favorable karyotypes, suggesting
View Article and Find Full Text PDF

Additional sex combs-like 1 (ASXL1), an epigenetic modulator, is frequently mutated in myeloid neoplasms. Recent analyses of mutant ASXL1 conditional knockin (ASXL1-MT-KI) mice suggested that ASXL1-MT alone is insufficient for myeloid transformation. In our previous study, we used retrovirus-mediated insertional mutagenesis, which exhibited the susceptibility of ASXL1-MT-KI hematopoietic cells to transform into myeloid leukemia cells.

View Article and Find Full Text PDF

In this work, we utilized spontaneously hypertensive rats (SHR) and Wister Kyoto rats (WKY), from which the SHR was established, to evaluate the effects of whole-body acute radiation on the cardiovascular system at doses from 0 to 4 Gy. In the irradiated SHR, the systolic blood pressure (SBP) increased with increasing dose, while body weight gain decreased with increasing radiation dose. Furthermore, pathological observations of SHR demonstrated that the number of rats with cystic degeneration in the liver increased with increasing dose.

View Article and Find Full Text PDF
Article Synopsis
  • - Loss-of-function mutations in the TET2 gene are commonly found in acute myeloid leukemia (AML) and preleukemic hematopoietic stem cells (HSCs) in older individuals.
  • - The study involved creating various genetically modified mice to investigate the effects of reduced TET function on AML development, leading to three different groups: T2ΔT3, ΔT2T3, and ΔT2ΔT3.
  • - The results showed that mice lacking both TET2 and TET3 (ΔT2ΔT3) died quickly from aggressive AML, while those with partial deficiencies had longer survival times, suggesting that mutations in TET genes are critical for AML progression. *
View Article and Find Full Text PDF